During the past decade, University of Louisville/Norton Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Louisville/Norton Hospital" are "Patients Indicated for a PICC for Any Medical Condition" (1 trials) and "Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein" (1 trials). Many other conditions were trialed in "University of Louisville/Norton Hospital" in a lesser frequency.

Most popular intervention types in "University of Louisville/Norton Hospital" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bard® Dual-Lumen PowerPICC SOLO2®" (1 trials), "BioFlo™ Peripherally Inserted Central Catheter (PICC)" (1 trials) and "Zilver Vena Venous Self-Expanding Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Louisville/Norton Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Louisville/Norton Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Louisville/Norton Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Louisville/Norton Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".